These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6348017)

  • 21. [Beta-lactam and aminoglycoside resistant phenotypes in enterobacteria isolated in pediatrics].
    Ben Hassen A; Chourou O; Fendri C; Kammoun A; Ben Redjeb S
    Bull Soc Pathol Exot; 1991; 84(2):145-53. PubMed ID: 1914045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of 6'- and 6'''-N-acylation of aminoglycosides as a strategy to overcome bacterial resistance.
    Shaul P; Green KD; Rutenberg R; Kramer M; Berkov-Zrihen Y; Breiner-Goldstein E; Garneau-Tsodikova S; Fridman M
    Org Biomol Chem; 2011 Jun; 9(11):4057-63. PubMed ID: 21365081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. armA and aminoglycoside resistance in Escherichia coli.
    González-Zorn B; Teshager T; Casas M; Porrero MC; Moreno MA; Courvalin P; Domínguez L
    Emerg Infect Dis; 2005 Jun; 11(6):954-6. PubMed ID: 15963296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 7-Hydroxytropolone: an inhibitor of aminoglycoside-2"-O-adenylyltransferase.
    Allen NE; Alborn WE; Hobbs JN; Kirst HA
    Antimicrob Agents Chemother; 1982 Nov; 22(5):824-31. PubMed ID: 6185088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China.
    Zhang C; Xu X; Pu S; Huang S; Sun J; Yang S; Zhang L
    Infect Genet Evol; 2014 Oct; 27():271-6. PubMed ID: 25107431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of the mechanisms of action on the bacterial cell of a new antimicrobial drug: nifurzide (author's transl)].
    Videz S; Perrier J; Gounot AM
    Ann Pharm Fr; 1981; 39(5):451-62. PubMed ID: 7034623
    [No Abstract]   [Full Text] [Related]  

  • 27. [Aminoglycoside antibodies: mechanism of action and resistance].
    Tanaka N
    Nihon Saikingaku Zasshi; 1986 May; 41(3):587-601. PubMed ID: 3528555
    [No Abstract]   [Full Text] [Related]  

  • 28. [Inhibition of the diffusion of plasmids by a nitrofuran derivative].
    Michel-Briand Y; Laporte JM
    C R Seances Acad Sci III; 1982 Feb; 294(5):249-52. PubMed ID: 6804030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanism of action of nourseothricin and bacterial resistance and cross-resistance to this antibiotic].
    Haupt I; Thrum H
    Arch Exp Veterinarmed; 1986 Sep; 40(5):676-81. PubMed ID: 3028299
    [No Abstract]   [Full Text] [Related]  

  • 30. [On testing the sensitivity of bacteria to nitrofurans. 2. Determination of 5-nitrofuraldehyde-(2)-semicarbazone concentration in the diffusion area during the scatter test].
    Weuffen W; Bĕhounková L; Kappe D
    Z Gesamte Hyg; 1968 Mar; 14(3):194-6. PubMed ID: 4896791
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of some aminoglycosides upon a drug dependent Escherichia coli strain.
    Gadó I; Dumbovich I
    Acta Microbiol Acad Sci Hung; 1975; 22(2):95-104. PubMed ID: 1092134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross resistance between nitrofurans and 5-nitroimidazoles in aerobic and microaerophilic bacteria.
    Devriese LA; Hommez J
    Zentralbl Veterinarmed B; 1978 Dec; 25(10):849-52. PubMed ID: 369238
    [No Abstract]   [Full Text] [Related]  

  • 33. A novel multidrug resistance plasmid isolated from an Escherichia coli strain resistant to aminoglycosides.
    Sun H; Li S; Xie Z; Yang F; Sun Y; Zhu Y; Zhao X; Jiang S
    J Antimicrob Chemother; 2012 Jul; 67(7):1635-8. PubMed ID: 22499999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of nitrofuran preparations on antibiotic-resistant pathogens].
    Kozhukhar' IG; Grinmaer TV; Bass TM; Chernomordik AB
    Vrach Delo; 1972 Feb; 2():144-7. PubMed ID: 4563631
    [No Abstract]   [Full Text] [Related]  

  • 35. The contribution of a novel ribosomal S12 mutation to aminoglycoside resistance of Escherichia coli mutants.
    Gill AE; Amyes SG
    J Chemother; 2004 Aug; 16(4):347-9. PubMed ID: 15332709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Development of resistance to difuracil (PAP-49) in bacteria and its activity in combination with other antibacterial drugs].
    Pavlov PA
    Antibiot Khimioter; 1997; 42(8):34-7. PubMed ID: 9412411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a cinodine-resistant mutant of Escherichia coli.
    Osburne MS
    J Antibiot (Tokyo); 1995 Nov; 48(11):1359-61. PubMed ID: 8557583
    [No Abstract]   [Full Text] [Related]  

  • 38. Aminoglycoside resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates from Western Norway.
    Lindemann PC; Risberg K; Wiker HG; Mylvaganam H
    APMIS; 2012 Jun; 120(6):495-502. PubMed ID: 22583362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotics and apochlorosis. 3. Effect of 5-nitrofurans on the chloroplast system of Euglena gracilis.
    Ebringer L; Jurásek A; Kada R
    Folia Microbiol (Praha); 1967; 12(2):151-6. PubMed ID: 4963245
    [No Abstract]   [Full Text] [Related]  

  • 40. High prevalence of cross-resistance to aminoglycosides in fluoroquinolone-resistant Escherichia coli clinical isolates.
    Tsukamoto N; Ohkoshi Y; Okubo T; Sato T; Kuwahara O; Fujii N; Tamura Y; Yokota S
    Chemotherapy; 2013; 59(5):379-84. PubMed ID: 24852043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.